Clinical Trial: A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058545) titled 'A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control' on June 18.

Brief Summary: This study is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of CJC-1134-PC Injection Administered Once Weekly in Antidiabetic Treatment-naive Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

Study Start Date: April 16, 2021

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus - Poor Control

Intervention: DRUG: CJC-1134-PC Injection

Double-blind Treat...